Metagenomi: Pioneering next-gen gene-editing systems to treat genetic diseases.
Hunterian Medicine: Innovating in gene-editing and CRISPR technology to cure genetic diseases.
Emendo Biotherapeutics: Advancing gene therapy with next-gen gene-editing tools for genetic disorders.
Cellomics Technology LLC: A biotech firm specializing in lentivirus production and gene manipulation.
eGenesis: Revolutionizing transplantation with a gene editing platform for human-compatible organs.
US-based Synthego Corp. provides software solutions for biological research, primarily serving California.
Acrigen Biosciences: Precision gene-editing tech firm developing therapies for genetic disorders.
Amber Bio, a San Francisco-based biotech firm, pioneers gene editing to reach untapped patient groups.
Cambridge-based Nvelop Therapeutics offers gene editing solutions for major unmet disease needs.
Arbor Biotechnologies: Pioneering biodiscovery with AI, genome sequencing, and high-throughput screening.
CellFE: A cell engineering startup innovating efficient gene-editing delivery via microfluidic devices.
St. Louis-based Inflection Point Genetics develops precise gene editing technology to advance genetics research.
NY-based Helex leverages genomics and intelligent data to create and distribute therapy-specific gRNAs.
Editas Medicine, Inc.: A clinical-stage biotech firm pioneering CRISPR-based therapies for rare diseases.
Tome Biosciences: Pioneering programmable gene insertion via CRISPR for precise genome editing.
Cambridge-based Intellia Therapeutics pioneers gene editing therapies for genetic diseases.
KBioBox: Advanced bioinformatics tech firm offering precise gene editing applications since 2013.
iECURE: A gene editing company dedicated to curing diseases with high unmet needs.